Elucid Appoints Dr. Kelly Huang as CEO. by Executive Hires 07/22/2024 Leave a Comment. Dr. Kelly Huang, CEO at ElucidWhat You Should Know: – Elucid, a company pioneering AI-powered medical technology for cardiovascular disease (CVD), has named Dr. Kelly Huang, PhD as its new President and Chief Executive Officer (CEO)

Elucid, a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, today an

Growth-focused leader will help bring the company’s AI-powered cardiovascular technology to marketBOSTON--(BUSINESS WIRE)-- Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, has hired Andrew Miller as its chief technology officer (CTO). In this role, Andrew will lead the technological strategy and oversee the engineering team’s execution. Elucid’s software is the only FDA-cleared non-invasive tool able to accurately characterize arterial plaque, simulating what pathologists would see under a microscope and establishing a histologic ground truth. Elucid is also pursuing an indication for FFRCT, uniquely derived from its PlaqueIQ technology, to non-invasively measure coronary blockages and the extent of ischemia.“We’re thrilled to welcome Andrew as CTO. He has an incredible technological skillset and proven track record in building high-performing technology teams across numerous successful organizations throughout his career,” said Blake Richards, chief executive officer, Elucid. “A true thought leader, his expertise executing vision and growing organizations will help propel Elucid as we grow commercially and realize the next phase of our mission to provide comprehensive and accurate clinical insights that enable unprecedented precision healthcare for vascular disease.”Miller is a health technology veteran with an acumen for transforming startups and growth-stage companies into mature organizations